• Tau Ser356, Alzheimer’s Pathology, and NUAK Inhibition

  2026-09-23

  Taylor et al. report that tau phosphorylated at serine 356 (p-tau Ser356) increases with Alzheimer’s disease neuropathological stage and is commonly found in neurofibrillary tangles, with array tomography also showing its localization near synapses. Their slice-culture experiments show that WZ4003 lowers p-tau Ser356 in live human brain tissue, while mouse slices show broader changes in tau and neuronal and synaptic proteins—an important difference for interpreting NUAK-inhibitor studies.

• Linagliptin and the p-Tau Ser356 Translation Gap

  2026-09-23

  A translational framework for interpreting p-tau Ser356 biology, designing human brain slice experiments, and evaluating Linagliptin (BI-1356) without overstating evidence from a NUAK inhibitor study.

• ApexPrep DNA Plasmid Miniprep Kit Workflow

  2026-09-22

  Build reproducible plasmid workflows for cloning, sequencing, and AML gene-regulation studies with one alkaline-lysis platform. The ApexPrep DNA Plasmid Miniprep Kit combines support for high- and low-copy vectors with a practical troubleshooting framework for obtaining molecular biology grade plasmid DNA.

• Ruxolitinib: From JAK Inhibition to Immune Profiling

  2026-09-22

  Ruxolitinib (INCB018424) is more than a potent JAK1/2 inhibitor: its experimental value depends on matching pathway, progenitor, and immune readouts to the biological question. This guide connects quantitative pharmacology with high-dimensional immune profiling and explains how to design more interpretable combination studies.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-09-21

  Breen and colleagues developed a drug-sensitized Saccharomyces cerevisiae platform that substantially improves detection of TOR pathway inhibitors compared with a wild-type strain background. The study also shows that canagliflozin produced no detectable TOR-dependent growth phenotype in this assay, illustrating how pathway-focused screening can distinguish metabolic research tools from candidate mTOR inhibitors.

• Ferrostatin-1 (Fer-1) in Ferroptosis Assays

  2026-09-21

  Ferrostatin-1 (Fer-1) provides a selective rescue control for distinguishing lipid peroxidation-driven cell death from nonspecific toxicity. This practical guide applies Fer-1 to erastin and butyrate workflows, 3D lung cancer stem-cell assays, and neurodegenerative disease models while emphasizing dose selection, orthogonal readouts, and troubleshooting.

• SARS-CoV-2 N Protein Rewires GADD34 Immunity

  2026-09-20

  Liu et al. identify an atypical stress-granule mechanism in which SARS-CoV-2 nucleocapsid protein recruits GADD34 mRNA into N/G3BP1-positive foci, weakening IRF3-dependent interferon signaling. The work connects RNA localization, stress-granule biology, and viral immune evasion while suggesting experimental strategies for dissecting RNA–protein interactions.

• Bestatin Chemistry Dissects Jasmonate Signaling

  2026-09-19

  The reference study established bestatin as a chemical genetics probe that activates COI1-dependent jasmonate responses while remaining partly uncoupled from jasmonic acid biosynthesis. By combining transcriptional profiling, developmental assays, and bestatin-resistant Arabidopsis mutants, the authors identified a practical route to discovering previously unrecognized regulators of plant hormone signaling.

• DM-β-CD Raises Mianserin HCl Cytotoxicity

  2026-09-18

  The reference study characterized how heptakis (2,6-di-O-methyl)-β-cyclodextrin interacts with Mianserin HCl and tested whether complexation reduces cellular toxicity. Instead, the inclusion system increased toxicity in B14 cell assays, showing that improved solubility and host–guest binding do not necessarily produce a safer antidepressant formulation.

• Trelagliptin Succinate: Mechanism and Research Use

  2026-09-18

  Trelagliptin succinate, also called SYR-472 succinate, is a long-acting DPP-4 inhibitor used in diabetes mellitus research. Evidence supports incretin-related glucose regulation and an experimental AMPK/SOX-9 protective effect in IL-1β-stressed human chondrocytes.

• CX-5461: A Mechanism-First Cancer Research Guide

  2026-09-17

  CX-5461 is an RNA polymerase I inhibitor that connects rRNA transcriptional stress with DNA damage, mitotic catastrophe, autophagy, and senescence. This guide presents a mechanistic assay framework for interpreting solid tumor growth inhibition and cisplatin-response studies without mistaking a single endpoint for target engagement.

• Berberine hydrochloride Workflows for Gut-Bone Research

  2026-09-17

  Build reproducible metabolic, intestinal-barrier, and osteoimmune experiments around a well-characterized berberine hydrochloride research reagent. This guide translates tuft-cell and gut-bone findings into practical formulation, assay, comparison, and troubleshooting decisions without overextending preclinical evidence.

• Elobixibat hydrate: IBAT Research Workflows

  2026-09-16

  Build mechanistic assays around Elobixibat hydrate, a selective ileal bile acid transporter inhibitor that links bile acid redistribution with intestinal secretion, motility, and TGR5–GLP-1 signaling. This guide separates evidence-backed clinical context from practical starting conditions for constipation, colonoscopy preparation, and metabolic research.

• Elobixibat Hydrate: IBAT Mechanism and Use

  2026-09-16

  Elobixibat hydrate is a selective ileal bile acid transporter inhibitor that increases intestinal bile acid exposure and supports bowel motility. Product information describes oral use in chronic idiopathic constipation, bowel preparation prior to colonoscopy, and metabolic research involving type 2 diabetes mellitus.

• Peroxynitrite–Ca2+ Signaling in Cardiac I/R Injury

  2026-09-15

  Liu et al. define a mechanistic pathway linking hyperhomocysteinemia to cardiac microvascular endothelial necroptosis during ischemia–reperfusion. Their cell and rat studies place peroxynitrite-driven ER stress, IP3R-dependent Ca2+ transfer, mitochondrial overload, and membrane injury in a connected sequence, while pharmacological IP3R inhibition improves cardiac outcomes.

8630 records 1/576 page Next 12345 下5页 Last page